Goldman Sachs’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.5M	Buy	1,001,527 +705,649	+238%	+$13.5M	﹤0.01%	2625
2025 Q4	$4.64M	Buy	295,878 +194,734	+193%	+$2.62M	﹤0.01%	3820
2025 Q3	$749K	Sell	101,144 -247,064	-71%	-$1.31M	﹤0.01%	5242
2025 Q2	$1.57M	Sell	348,208 -7,904	-2%	-$35.3K	﹤0.01%	4363
2025 Q1	$1.65M	Buy	356,112 +196,238	+123%	+$1.2M	﹤0.01%	4313
2024 Q4	$1.11M	Sell	159,874 -18,731	-10%	-$141K	﹤0.01%	4750
2024 Q3	$947K	Buy	178,605 +86,256	+93%	+$435K	﹤0.01%	4669
2024 Q2	$345K	Buy	92,349 +76,585	+486%	+$390K	﹤0.01%	5021
2024 Q1	$111K	Sell	15,764 -21,414	-58%	-$127K	﹤0.01%	5233
2023 Q4	$210K	Sell	37,178 -17,032	-31%	-$66.8K	﹤0.01%	5133
2023 Q3	$260K	Buy	54,210 +8,874	+20%	+$57.1K	﹤0.01%	4954
2023 Q2	$311K	Buy	45,336 +13,103	+41%	+$84.7K	﹤0.01%	4990
2023 Q1	$251K	Sell	32,233 -11,729	-27%	-$81.6K	﹤0.01%	5197
2022 Q4	$335K	Buy	43,962 +10,668	+32%	+$88.9K	﹤0.01%	5088
2022 Q3	$272K	Sell	33,294 -6,822	-17%	-$62.7K	﹤0.01%	5342
2022 Q2	$388K	Sell	40,116 -9,701	-19%	-$97.5K	﹤0.01%	5260
2022 Q1	$698K	Buy	49,817 +15,071	+43%	+$209K	﹤0.01%	5111
2021 Q4	$710K	Buy	34,746 +15,627	+82%	+$327K	﹤0.01%	5110
2021 Q3	$426K	Sell	19,119 -89,381	-82%	-$2.56M	﹤0.01%	5295
2021 Q2	$2.46M	Buy	+108,500	New	+$2.21M	﹤0.01%	4018